 After a steady decline for the last 50 years, the prevalence of tobacco use in the United States has reached a plateau of approximately 23. Currently available treatments among adults are expensive and not efficacious for all tobacco users. New pharmacologic agents need to be developed and tested to achieve the Healthy People 2010 goal of less than a 12 adult tobacco use prevalence. 